Panagora Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,438
| Closed | -$1.54M | – | 1202 |
|
|
2025
Q1 | $1.54M | Sell |
49,438
-14,226
| -22% | -$443K | 0.01% | 578 |
|
|
2024
Q4 | $1.62M | Buy |
63,664
+544
| +0.9% | +$13.9K | 0.01% | 560 |
|
|
2024
Q3 | $1.79M | Hold |
63,120
| – | – | 0.01% | 556 |
|
|
2024
Q2 | $1.66M | Sell |
63,120
-129,378
| -67% | -$3.41M | 0.01% | 569 |
|
|
2024
Q1 | $5.85M | Sell |
192,498
-88,517
| -31% | -$2.69M | 0.03% | 309 |
|
|
2023
Q4 | $7.89M | Buy |
281,015
+215,142
| +327% | +$6.04M | 0.04% | 255 |
|
|
2023
Q3 | $1.79M | Buy |
65,873
+16,525
| +33% | +$448K | 0.01% | 561 |
|
|
2023
Q2 | $1.52M | Hold |
49,348
| – | – | 0.01% | 645 |
|
|
2023
Q1 | $1.78M | Buy |
49,348
+17,778
| +56% | +$641K | 0.01% | 616 |
|
|
2022
Q4 | $1.25M | Sell |
31,570
-19,088
| -38% | -$754K | 0.01% | 801 |
|
|
2022
Q3 | $2.04M | Sell |
50,658
-66,325
| -57% | -$2.66M | 0.01% | 593 |
|
|
2022
Q2 | $4.92M | Buy |
116,983
+105,620
| +930% | +$4.44M | 0.03% | 385 |
|
|
2022
Q1 | $443K | Hold |
11,363
| – | – | ﹤0.01% | 1251 |
|
|
2021
Q4 | $453K | Hold |
11,363
| – | – | ﹤0.01% | 1255 |
|
|
2021
Q3 | $411K | Sell |
11,363
-2,498
| -18% | -$90.4K | ﹤0.01% | 1390 |
|
|
2021
Q2 | $568K | Sell |
13,861
-1,647
| -11% | -$67.5K | ﹤0.01% | 1277 |
|
|
2021
Q1 | $676K | Buy |
15,508
+8,349
| +117% | +$364K | ﹤0.01% | 1187 |
|
|
2020
Q4 | $358K | Buy |
+7,159
| New | +$358K | ﹤0.01% | 1354 |
|